References
- Lauritzen A.F., Ralfkiaer E. Histiocytic sarcomas. Leukemia and Lymphoma 1995; 18: 73–80
- Franchino C., Reich C., Distenfeld A., Ubriaco A., Knowles D.M. A clinicopathologically distinctive primary splenic histiocytic neoplasm. Demonstration of its histiocytic derivation by immunophenotypic and molecular genetic analysis. Am J Surg Pathol 1988; 12: 398–404
- Byrne G.E., Rappaport H. Malignant histiocytosis. Malignant diseases of the hemopoietic system, GANN Monograph on Cancer Research 15, K. Akazaki, H. Rappaport, C.W. Berard, J.M. Benett, E. Ishizaka. University of Tokyo Press, Tokyo 1973; 145–162
- Tseng A., Jr, Coleman N., Cox R.S., Colby T.V., Turner R.R., Horning S.J., Rosenberg S.A. The treatment of malignant histiocytosis. Blood 1984; 64: 48–53
- Roholl P.J.M., Kleyne J., Prins M.E.F., Hooijkaas H., Vroom T.M., Van Unnik A.M. Immunologic marker analysis of normal and malignant histiocytes. A comparative study of monoclonal antibodies for diagnostic purposes. Am J Clin Pathol 1988; 89: 187–194
- Hsu S.M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem and cytochem 1981; 29: 577–580
- Brandtzaeg P., Jones D.B., Flavell D.J., Fagerhol M.K. MAC387 antibody and detection of formalin resistant myelomonocytic LI antigen. J Clin Pathol 1988; 41: 963–970
- Vardiman J.W., Byrne G.E., Rappaport H. 1975
- Malignant histiocytosis with massive splenomegaly in asymptomatic patients. A possible chronic form of the disease. Cancer, 36: 419–427
- Ezdinli E.Z., Kucuk O., Chedid A., Sinclair T.F., Thomas K., Singh S., Sarpel S., Jovanovic L. Hypogammaglobulinemia and hemophagocytic syndrome associated with lymphoproliferative disorders. Cancer 1986; 57: 1024–1037